8.6 Returning & Reusing Drugs: Destruction, Donation & Charitable Clinic Pharmacies

8.6 Returning & Reusing Drugs: Destruction, Donation & Charitable Clinic Pharmacies

Quick Answer: Once a prescription leaves the pharmacy, Tennessee treats it as unfit to return to stock. Rule 1140-03-.03(8) permits a pharmacy to receive back "any portion of an order that has been taken from the premises" in exactly two circumstances: (a) as authorized under Rule 1140-04-.10, the institutional-pharmacy return provision; or (b) for the purpose of collection for disposal or destruction, provided participation in the program is voluntary and the collection and destruction are conducted in accordance with 21 CFR Part 1317. Rule 1140-03-.10(3) adds that medications may be returned to and received by the pharmacy "if received expressly for the purpose of destruction," provided the pharmacy is equipped for it and has a policy for complete and timely destruction. Redispensing of donated medicine is confined to the charitable clinic pharmacy program under the Nina Norman Prescription Drug Donation Act of 2006 (T.C.A. § 63-10-501 et seq., Rule Chapter 1140-12).

---

1. The Default Rule: Dispensed Means Gone

The NABP Competency Statements list "returning or reusing drugs" as competency 2.4 inside the 33%-weighted Pharmacist Practice area. Every jurisdiction answers it differently, and Tennessee's answer is restrictive. The governing sentence sits at the end of the prescription-order rule rather than in a rule with an obvious caption, which is why candidates miss it:

Rule 1140-03-.03(8): "It is permissible for any pharmacy practice site, pharmacist, or pharmacy intern or pharmacy technician under the supervision of a pharmacist, or any other place of business engaged in compounding and dispensing prescription drugs … to receive from any patient or other person the return of any portion of an order that has been taken from the premises … only if authorized: (a) Pursuant to Tennessee Board of Pharmacy rule 1140-04-.10; or (b) For the purpose of collection for disposal or destruction of any prescription drug; provided that participation in the program shall be voluntary, and such collection and destruction shall be conducted in accordance with the provisions of 21 CFR § 1317."

Three drafting choices carry exam weight:

1. "Only if authorized." The rule is framed as a prohibition with two carve-outs, not as a general permission with limits. If a fact pattern does not land inside (a) or (b), the answer is that the pharmacy may not take the product back.
2. The cross-reference to Chapter 1140-04. The one reuse pathway the rule preserves is institutional, found in Rule 1140-04-.10. Community pharmacy has no counterpart.
3. "Voluntary." A pharmacy cannot be compelled to operate a take-back receptacle, and a patient cannot be compelled to use one.

---

2. Receipt for Destruction — Rule 1140-03-.10(3)

The Conditions for Delivery or Sale rule reinforces the same boundary from the other direction:

"Medications may be returned to, and received by, the pharmacy/pharmacist if received expressly for the purpose of destruction of the returned medication, provided the pharmacy is equipped for doing so with a policy for complete and timely destruction of medications and in strict accordance with 1140-03-.03(8)."

The Federal Overlay — 21 CFR Part 1317

Part 1317 is DEA's disposal framework. For an authorized collector, the operative controls are the locked, tamper-evident inner liner, the requirement that liners be installed, removed, sealed, and transferred by or under the supervision of two employees, and the prohibition on pharmacy staff handling, counting, sorting, or inventorying the contents of a returned-drug liner. That last point is a common exam trap: a pharmacist who opens a take-back liner to inventory what was surrendered has created a violation, not a record.

---

3. Damaged, Outdated and Deteriorated Stock

Two adjacent rules complete the picture, and both are frequently confused with the patient-return rules above because they use the word "return."

Rule 1140-03-.10(1) and (2) — damaged product. No package containing a prescription drug, device, or related material damaged by fire, heat, smoke, water, or other causes may be placed in stock, offered for sale, dispensed, or otherwise sold. Any repossession proceedings must be performed with the approval of the Board. And "under no circumstances" may such damaged product be delivered or handed over to an insurance company, adjustor, salvage company, or other person unless approved by the Board prior to delivery. A pharmacy that hands its flood-damaged stock to an insurance adjuster before calling the Board has violated the rule regardless of the claim's merits.

Rule 1140-03-.11 — outdated and deteriorated drugs. "The owner or pharmacist in charge of a pharmacy practice site shall immediately return or destroy all outdated, defective, or deteriorated prescription drugs and devices and related materials; except that the destruction of controlled substances listed in any schedule shall be performed by a Board approved agent or vendor."

┌─────────────────────────────────────────────────────────────────────────────┐
│              WHICH RULE GOVERNS? A DECISION PATH FOR RETURNS                │
├─────────────────────────────────────────────────────────────────────────────┤
│ Product came back from a PATIENT                                            │
│   └─> Reuse?  Only via Rule 1140-04-.10 (institutional).                     │
│   └─> Otherwise: accept ONLY for destruction — Rule 1140-03-.03(8)(b) and    │
│       Rule 1140-03-.10(3), voluntary, under 21 CFR Part 1317.               │
│                                                                             │
│ Product is PHARMACY STOCK that is outdated, defective, or deteriorated      │
│   └─> Rule 1140-03-.11: owner/PIC must IMMEDIATELY return or destroy.        │
│   └─> If controlled (ANY schedule): destruction by a BOARD-APPROVED agent    │
│       or vendor; reverse distribution documented on DEA Form 222 for C-II    │
│       and invoices for C-III–V; on-site destruction on DEA Form 41.          │
│                                                                             │
│ Product is PHARMACY STOCK DAMAGED by fire, heat, smoke, or water            │
│   └─> Rule 1140-03-.10(1)-(2): never restock, sell, or dispense; no          │
│       delivery to an insurer, adjustor, or salvage company without PRIOR     │
│       Board approval; repossession requires Board approval.                 │
└─────────────────────────────────────────────────────────────────────────────┘

---

4. The One Redispensing Program: Charitable Clinic Pharmacies

Tennessee does permit donated medicine to be redispensed, but only inside a purpose-built statutory program. T.C.A. § 63-10-501 et seq. is the Nina Norman Prescription Drug Donation Act of 2006, and Rule Chapter 1140-12 implements it. The rule's own purpose clause describes the Act as enacted "to develop a prescription drug redispensing program that authorizes charitable clinic pharmacies to redispense medicines to indigent patients that would otherwise be destroyed."

Two documents define the program's risk allocation and are worth memorizing by name:

• The donor patient form (1140-12-.07) carries the donor's signature (or that of the donor's representative if the donor is deceased or not competent) and a statement that participation "shall not be used as an independent basis for a civil, criminal, or disciplinary action" against the donor, the donor's estate, the health care provider, the charitable clinic, the Department of Health, the Board, or the charitable clinic pharmacy and its personnel, so long as they abide by Board rules.
• The waiver form (1140-12-.08) is signed by the indigent recipient and identifies the patient, the drug, quantity, prescription number, date, and dispensing charitable clinic pharmacy, and releases the institutional facility, the donor patient, and the donor patient's estate from liability.

Civil penalties under Rule 1140-12-.09 run $0 to $1,000 per cited violation, with each day of continued violation constituting a separate violation — the same scale as the general civil penalty rule at 1140-08-.01.

Exam framing. If a question asks whether a community pharmacy may accept a nursing home's unused, unopened, sealed unit-dose cards back into stock for resale, the answer is no — that is neither the institutional pathway at Rule 1140-04-.10 nor the charitable clinic pharmacy program, and Rule 1140-03-.03(8) permits receipt only for destruction. If the question instead describes a licensed charitable clinic pharmacy redispensing donated medicine to an indigent patient with a signed donor form and waiver, the answer flips.

---

5. Practical Exam Scenarios

Scenario 1: The Unopened Bottle

Case: A patient returns an unopened, sealed bottle of atorvastatin dispensed two days earlier and asks for a refund and restocking, noting the seal has never been broken. Legal Analysis: The pharmacy may not restock it. Rule 1140-03-.03(8) permits receipt of a portion of an order taken from the premises only as authorized under Rule 1140-04-.10 or for collection for disposal or destruction. An intact factory seal does not create a third exception. The lawful handling is receipt expressly for destruction under Rule 1140-03-.10(3), through a voluntary program compliant with 21 CFR Part 1317; whether to issue a refund is a business decision that does not change the disposition of the product.

Scenario 2: Sorting the Take-Back Liner

Case: A pharmacist operating a take-back receptacle opens the inner liner at the end of the month to log which controlled substances were surrendered, believing this creates a useful diversion-monitoring record. Legal Analysis: This is prohibited. Under 21 CFR Part 1317, the inner liner must remain sealed and its contents may not be handled, counted, sorted, or inventoried by pharmacy personnel; liners are installed, removed, sealed, and transferred under the supervision of two employees. Rule 1140-03-.03(8)(b) incorporates Part 1317 by reference, so the federal breach is simultaneously a Tennessee rule violation.

Scenario 3: Expired Hydrocodone on the Shelf

Case: A PIC discovers three bottles of expired hydrocodone/acetaminophen during a shelf sweep and asks a technician to empty them into the pharmacy's sharps container. Legal Analysis: Rule 1140-03-.11 requires the owner or PIC to immediately return or destroy outdated, defective, or deteriorated drugs, but destruction of controlled substances in any schedule must be performed by a Board-approved agent or vendor. Ad hoc on-site disposal by a technician is unlawful. The compliant routes are transfer to a registered reverse distributor — documented on a DEA Form 222 for Schedule II and on invoices for Schedules III–V — or destruction recorded on DEA Form 41 through an authorized process.